free web stats

CMV News

CMV News and Insights from VBI Vaccines

VBI Vaccines to Continue Enrolling Participants in the Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate Following Successful Data Safety Monitoring Board Review

By | Cytomegalovirus ("CMV"), Press Releases | No Comments
VBI Vaccines Inc. (Nasdaq: VBIV) (TSX: VBV) (“VBI”) today announced that, following a review of safety data from the limited safety immunization period, the Data Safety Monitoring Board (“DSMB”) has no objection to VBI continuing with the enrollment of participants...
Read More

Researchers Explore the Mechanisms by Which CMV Infection May Impact Fetal Brain Development

By | Cytomegalovirus ("CMV") | No Comments
Congenital cytomegalovirus (“CMV”) infection is a leading prenatal cause of intellectual disability, nonhereditary sensorineural hearing loss, and can bring about other long-term neurodevelopmental disabilities including cerebral palsy, vision impairment, and seizures. Approximately 10% of neonates with congenital CMV infection show...
Read More

Get Important News and Insights by Email